Topics
Astrocytoma | Treatment | Clinical trials | Temozolomide
Home > Publications > Topics > Astrocytoma > Treatment > Clinical trials > Temozolomide
Fleming JL, Pugh SL, Chang SM, McElroy JP, Becker AP, Aldape KD,
Shih HA, Ashby LS, Hunter GK, Bahary JP, Schultz CJ, Kavanagh BD,
Puduvalli VK, Robins HI, Werner-Wasik M, Mehta M, Chakravarti A.
Comprehensive Molecular Analysis in
NRG Oncology/RTOG 9813: A Phase III Study of Radiation and
Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic
Astrocytoma.
Int
J Radiat Oncol Biol Phys. 2025 Mar
29:S0360-3016(25)00284-6. doi:
10.1016/j.ijrobp.2025.03.043. PMID:
40164352. Interventional study˰
ˍ
Lin T, Ke S, Hu C, Assadi R, Huang J, Gupta S, Rawojc K, Kleinberg
L, Mukherjee D, Rincon-Torroella J, Weingart JD, Holdoff M,
Grossman S, Ahmed MM, Redmond KJ.
Low
Dose Fractionated Radiation Therapy As a Chemo-Potentiator of
Temozolomide for Recurrent Anaplastic Astrocytoma and
Glioblastoma: A Single-Arm Phase I/II Trial.
Int
J Radiat Oncol Biol Phys. 2025 Oct
24:S0360-3016(25)06396-5. doi:
10.1016/j.ijrobp.2025.10.014. PMID:
41138784. Interventional
study˰ ˍ
van den Bent MJ, Ghisai SA, Wick W, Sanson M, Brandes AA, Clement
PM, Erridge SC, Vogelbaum MA, Nowak AK, Baurain JF, Mason WP,
Wheeler H, Tabouret E, Gill S, Griffin M, Taal W, Rudà R,
Weller M, McBain C, Reijneveld JC, Enting RH, Tran S, Lesimple T,
Kocher M, Gijtenbeek A, Lim E, Herrlinger U, Hau P, Dhermain F,
Aldape K, Jenkins RB, Dubbink HJ, Kros JM, Wesseling P, Hoogstrate
Y, Nuyens S, Golfinopoulos V, Tesileanu CMS, Gorlia T, French P,
Baumert BG.
Concurrent and adjuvant
temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON;
EORTC study 26053-22054): final and exploratory analyses of a
randomised, open-label, phase 3 trial.
Lancet
Oncol. 2025 Dec 22;27(1):45-56.
doi:
10.1016/S1470-2045(25)00614-X. PMID:
41449147. Interventional study˰
ˍ